N-P Tyrosine PA

<strong>N-P Tyrosine PA</strong>_x000D_ <strong>Catalog number:</strong> B2019226_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 533.638_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> N-palmitoyl-tyrosine phosphoric acid (ammonium salt)_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Sridaran D, Bradshaw E, DeSelm C, Pachynski R, Mahajan K, Mahajan NP. Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach Cell Rep Med. 2023 Oct 17;4(10):101199._x000D_ 2: Angappulige DH, Mahajan NP, Mahajan K. Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppression Trends Cancer. 2024 Apr;10(4):369-381._x000D_ 3: Karamanavi E, McVey DG, van der Laan SW, Stanczyk PJ, Morris GE, Wang Y, Yang W, Chan K, Poston RN, Luo J, Zhou X, Gong P, Jones PD, Cao J, Kostogrys RB, Webb TR, Pasterkamp G, Yu H, Xiao Q, Greer PA, Stringer EJ, Samani NJ, Ye S. The FES Gene at the 15q26 Coronary-Artery-Disease Locus Inhibits Atherosclerosis Circ Res. 2022 Dec 2;131(12):1004-1017._x000D_ 4: Pietsch N, Chen CY, Kupsch S, Bacmeister L, Geertz B, Herrera-Rivero M, Siebels B, Voß H, Krämer E, Braren I, Westermann D, Schlüter H, Mearini G, Schlossarek S, van der Velden J, Caporizzo MA, Lindner D, Prosser BL, Carrier L. Chronic Activation of Tubulin Tyrosination Improves Heart Function Circ Res. 2024 Oct 11;135(9):910-932._x000D_ 5: Marchal M, Leroy V, Behal H, Dansin E, Paris N, Bordier S, Humez S, Escande F, Gauvain C, Cortot AB. Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers Target Oncol. 2023 Nov;18(6):927-939._x000D_ 6: Fiz F, Bini F, Gabriele E, Bottoni G, Garrè ML, Marinozzi F, Milanaccio C, Verrico A, Massollo M, Bosio V, Lattuada M, Rossi A, Ramaglia A, Puntoni M, Morana G, Piccardo A. Role of Dynamic Parameters of 18F-DOPA PET/CT in Pediatric Gliomas Clin Nucl Med. 2022 Jun 1;47(6):517-524._x000D_ 7: Chouhan S, Sridaran D, Weimholt C, Luo J, Li T, Hodgson MC, Santos LN, Le Sommer S, Fang B, Koomen JM, Seeliger M, Qu CK, Yart A, Kontaridis MI, Mahajan K, Mahajan NP. SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis Nat Commun. 2024 Jul 4;15(1):5629._x000D_ 8: Maiti A, DiNardo CD, Daver NG, Rausch CR, Ravandi F, Kadia TM, Pemmaraju N, Borthakur G, Bose P, Issa GC, Short NJ, Yilmaz M, Montalban-Bravo G, Ferrajoli A, Jabbour EJ, Jain N, Ohanian M, Takahashi K, Thompson PA, Loghavi S, Montalbano KS, Pierce S, Wierda WG, Kantarjian HM, Konopleva MY. Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia Blood Cancer J. 2021 Feb 1;11(2):25._x000D_ 9: Sridaran D, Chouhan S, Mahajan K, Renganathan A, Weimholt C, Bhagwat S, Reimers M, Kim EH, Thakur MK, Saeed MA, Pachynski RK, Seeliger MA, Miller WT, Feng FY, Mahajan NP. Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance Nat Commun. 2022 Nov 14;13(1):6929._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/36012123">10: Tan AC, Pavlakis N. Anti-Angiogenic Therapy in ALK Rearranged Non-Small Cell Lung Cancer (NSCLC) Int J Mol Sci. 2022 Aug 9;23(16):8863. </a>_x000D_ _x000D_ <strong>Products Related to N-P Tyrosine PA can be found at</strong> <a href="https://moleculardepot.com/product-category/Lipids/"> Lipids</a>